EXPRESS: Assessment of Pain-Related Biomarkers in Migraine and Tension Headache Patients Pre- and Post-Botulinum Toxin Therapy.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- EXPRESS: Assessment of Pain-Related Biomarkers in Migraine and Tension Headache Patients Pre- and Post-Botulinum Toxin Therapy.
- Published In:
- Molecular pain, 17448069261422070 (2026)
- Authors:
- Abbas, Afrah Abdulsahib, Aswad, Fawaz, Zaidan, Taghreed
- Database ID:
- RPEP-14686
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14686APA
Abbas, Afrah Abdulsahib; Aswad, Fawaz; Zaidan, Taghreed. (2026). EXPRESS: Assessment of Pain-Related Biomarkers in Migraine and Tension Headache Patients Pre- and Post-Botulinum Toxin Therapy.. Molecular pain, 17448069261422070. https://doi.org/10.1177/17448069261422070
MLA
Abbas, Afrah Abdulsahib, et al. "EXPRESS: Assessment of Pain-Related Biomarkers in Migraine and Tension Headache Patients Pre- and Post-Botulinum Toxin Therapy.." Molecular pain, 2026. https://doi.org/10.1177/17448069261422070
RethinkPeptides
RethinkPeptides Research Database. "EXPRESS: Assessment of Pain-Related Biomarkers in Migraine a..." RPEP-14686. Retrieved from https://rethinkpeptides.com/research/abbas-2026-express-assessment-of-painrelated
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.